Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.

Also called NCT03889249

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,600 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03889249
Other papers using this trial's data
  • Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial Stroke, 2023-11 DOI, PubMed 37800372
  • Effect of thrombolysis type on the efficacy of aspiration versus stent retriever first line thrombectomy: results from the AcT trial Journal of neurointerventional surgery, 2025-06-01 DOI, PubMed 39379314
  • Evaluating Differential Item Functioning in EQ-5D-5L in Acute Ischemic Stroke: Evidence From the ACT Trial Stroke, 2026-09 DOI, PubMed 42488952
  • Predictors and Consequences of Serious Adverse Events in Patients Treated With Thrombolysis: A Prespecified Secondary Analysis of the AcT Trial Journal of the American Heart Association, 2026-06-16 DOI, PubMed 42261967, PMC13323578 In the PMC Open Access subset under CC BY-NC-ND.
  • Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial Stroke, 2024-03 DOI, PubMed 38275116
  • Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial Stroke, 2025-05 DOI, PubMed 40123483

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03889249. Randomized; single masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2022-04-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
Acronym
AcT
Condition
Stroke, Acute
Condition
Thromboses, Intracranial
Intervention (Drug)
Tenecteplase
Intervention (Drug)
Alteplase
Lead sponsor
University of Calgary (class: other)

Record details

Record id
cardio:ct-nct03889249
Content hash
23defc05e2d16964956d1f089e09646d9eda5d2b1c3ccb9b3553d77e1a577d6a